Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.

JAMA Neurol.

Schapira AH, Fox SH, Hauser RA, Jankovic J, Jost WH, Kenney C, Kulisevsky J, Pahwa R, Poewe W, Anand R

doi: 10.1001/jamaneurol.

Parkinson’s Disease

Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of life

Neurology.

Sperling SA, Shah BB, Barrett MJ, Bond AE, Huss DS, Gonzalez Mejia JA, Elias WJ

doi: 10.1212/WNL.

Parkinson’s DiseaseAnxiety and Depression

Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study

Lancet Neurol.

Martínez-Fernández R, Rodríguez-Rojas R, Del Álamo M, Hernández-Fernández F, Pineda-Pardo JA, Dileone M, Alonso-Frech F, Foffani G, Obeso I, Gasca-Salas C, de Luis-Pastor E, Vela L, Obeso JA

doi: 10.1016/

Migraine and HeadacheMultiple Sclerosis

Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial

Lancet Neurol.

Oliveria SF, Rodriguez RL, Bowers D, Kantor D, Hilliard JD, Monari EH, Scott BM, Okun MS, Foote KD

doi: 10.1016/

RECOMMENDED

Parkinson’s Disease

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial

Lancet Neurol.

LeWitt PA, Hauser RA, Pahwa R, Isaacson SH, Fernandez HH, Lew M, Saint-Hilaire M, Pourcher E, Lopez-Manzanares L, Waters C, Rudzínska M, Sedkov A, Batycky R, Oh C, SPAN-PD Study Investigators

doi: 10.1016/S1474-4422(18)30405-8.

MRI-guided focused ultrasound thalamotomy in non-ET tremor syndromes

Neurology.

Fasano A, Llinas M, Munhoz RP, Hlasny E, Kucharczyk W, Lozano AM

doi: 10.1212/

Psychosis and Schizophrenia

The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease

Behav Neurol.

Divac N, Stojanović R, Savić Vujović K, Medić B, Damjanović A, Prostran M

doi: 10.1155/2016/4938154.

Parkinson’s Disease

Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson's Disease

N Engl J Med

Martínez-Fernández R, Máñez-Miró JU, Rodríguez-Rojas R, Del Álamo M, Shah BB, Hernández-Fernández F, Pineda-Pardo JA, Monje MHG, Fernández-Rodríguez B, Sperling SA, Mata-Marín D, Guida P, Alonso-Frech F, Obeso I, Gasca-Salas C, Vela-Desojo L, Elias WJ, Obeso JA

doi: 10.1056/NEJMoa2016311

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Lancet Neurol.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A

doi: 10.1016/S1474-

Related content

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.

Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of life

Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study

Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial

MRI-guided focused ultrasound thalamotomy in non-ET tremor syndromes

The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease

Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson's Disease

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial